Patent application number | Description | Published |
20100102787 | CONTROLLED POWER SUPPLY AND METHOD FOR PULSE LOAD - A method for supplying bursts of substantially constant voltage to a switched load via a voltage reservoir. Based on a predetermined current that is to be sourced by the load during an active portion of a switching cycle, computing an average current that should be fed to the voltage reservoir during an inactive portion of the switching cycle to ensure that sufficient energy will stored in the voltage reservoir to supply the load without completely draining the voltage reservoir. Supplying continuous energy to the voltage reservoir at a substantially constant current equal in magnitude to said average current. | 04-29-2010 |
20110006969 | POWER ARRAY FOR HIGH POWER PULSE LOAD - A controlled power supply comprising: a) an array of low voltage current sources; b) a plurality of switch power supplies coupled to each of the storage capacitors and respective ones of the pulse loads being coupled to each of the switch power supplies; c) each of the storage capacitors being configured for storing energy during an inactive portion of a load switching cycle of the respective switch power supply to which the corresponding storage capacitor is coupled when the pulse loads are inactive; d) a respective output capacitor in association with each of the switch power supplies for feeding voltage to the respective pulse loads during an active portion of the load switching cycle; and e) the respective storage capacitor being configured for supplying the stored energy via the respective to the respective switch power supply to which the storage capacitor is coupled to each of the pulse loads coupled to switch power supply during an active portion of the load switching cycle. | 01-13-2011 |
20130027277 | POWER ARRAY FOR HIGH POWER PULSE LOAD - A controlled power supply comprising: a) an array of low voltage current sources; b) a plurality of switch power supplies coupled to each of the storage capacitors and respective ones of the pulse loads being coupled to each of the switch power supplies; c) each of the storage capacitors being configured for storing energy during an inactive portion of a load switching cycle of the respective switch power supply to which the corresponding storage capacitor is coupled when the pulse loads are inactive; d) a respective output capacitor in association with each of the switch power supplies for feeding voltage to the respective pulse loads during an active portion of the load switching cycle; and e) the respective storage capacitor being configured for supplying the stored energy via the respective to the respective switch power supply to which the storage capacitor is coupled to each of the pulse loads coupled to switch power supply during an active portion of the load switching cycle. | 01-31-2013 |
20140354245 | SYSTEM, A METHOD AND A COMPUTER PROGRAM PRODUCT FOR CONTROLLING ELECTRIC POWER SUPPLY - A method for controlling electric power supply, the method comprising: (a) controllably down converting by a step-down power converter entry voltage from a power source and preventing up-conversion by a step-up power converter, substantially when the entry voltage is larger than a measured exit voltage and is in compliance with a first criterion that is based on the entry voltage and on the measured exit voltage; wherein the measured exit voltage is measured at an exit of both step-up power converter and the step-down power converter; and (b) controllably up converting by the step-up power converter the entry voltage and preventing down-conversion by the step-down power converter, substantially when the entry voltage is lower than the measured exit voltage and is in compliance with a second criterion that is based on the entry voltage and on the measured exit voltage. | 12-04-2014 |
Patent application number | Description | Published |
20080220968 | [1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg - The present invention relates to a chromatographic adsorbent for selectively adsorbing IgG, comprising the following formula | 09-11-2008 |
20090138208 | IMMUNOGLOBULIN G BINDING POCKET - The present invention relates to a human IgG binding pocket comprised of a first interacting surface, which originates from an IgG κ light chain, and a second interacting surface, which originates from an IgG heavy chain, which amino acids are strictly conserved between human IgGs of κ-type. The invention also embraces an isolated and purified polypeptide, which comprises said binding pocket. Further, the invention relates to various methods of using the novel binding pocket, such as in screening for identification of chemical entities capable of selective binding thereof, and in other experimental and/or virtual methods for design and/or identification of chemical entities capable of selective binding thereof. | 05-28-2009 |
20090259029 | [1, 2, 4] TRIAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AS CHROMATOGRAPHIC ADSORBENT FOR THE SELECTIVE ADSORPTION OF IGG - The present invention relates to a chromatographic adsorbent for selectively adsorbing IgG, comprising the following formula | 10-15-2009 |
20100009867 | MULTI-MODAL ION EXCHANGE CHROMATOGRAPHY RESINS - The present invention relates to a method of preparing a library of resins which are useful in chromatography, which method comprises creating a diversity of multi-modal ion exchange resins; and providing the diversity in a parallel system in which each resin is presented separated from the other resin(s). | 01-14-2010 |
20110039712 | PREPARATION OF LIQUID MIXTURES - A method of determining the relative component proportions of at least one each of: a buffer; an acid or a base; a solvent; and optionally a salt, for providing a liquid mixture of pre-defined pH and ionic strength, wherein the relative component proportions are determined using the equation of Debye-Hückel, wherein the ion size parameter a in the Debye-Hückel equation is determined as the weighted mean ion size of all species contributing to the ionic strength of the liquid mixture, and wherein the ionic strength of each species is used as weighting parameter. The present method is also applicable in a method of providing a liquid mixture. Further there is provided a buffer preparation device. | 02-17-2011 |
20120217192 | METHOD AND SYSTEM FOR PREPARATION OF LIQUID MIXTURES - A method for preparing a liquid flow having pre-defined characteristics by mixing liquid flows of at least two different component stock solutions with each other comprises the steps of determining a selected property value for one or more of the stock solutions by sensing, in a flow of each stock solution separately, at least one characteristic related to the property value for the stock solution, and based on the determined property value or values, mixing the stock solution flows in mixing ratios giving the desired mixed liquid flow. A system for carrying out the method comprises sensor means and a control unit, wherein the control unit is arranged to evaluate the characteristics sensed by the sensor means and provide relative ratios of stock solutions required to obtain a mixed liquid flow having the pre-defined characteristics. | 08-30-2012 |
20130081703 | METHOD OF PREPARING LIQUID MIXTURES - A method of preparing a mixed liquid flow having predetermined characteristics, including a predetermined value of a first property and a predetermined value of a second property, comprising the steps of:
| 04-04-2013 |
20130270492 | METHOD FOR PREDICTING THE CONDUCTIVITY OF A LIQUID MIXTURE - In a method of preparing a liquid solution by mixing ingredients according to a predetermined recipe, wherein at least one pair of species of the liquid solution is derived from a weak electrolyte and corresponds to an acid-base pair, the conductivity of the liquid solution is predicted by:
| 10-17-2013 |
Patent application number | Description | Published |
20090024072 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 01-22-2009 |
20090198172 | INTERVENTIONAL SHEATH WITH RETENTION FEATURES - A device for use in accessing and treating an artery comprises a sheath having a distal end adapted to be introduced into the artery, a proximal end, and a lumen extending between the distal and proximal ends. A retention feature is on the sheath, wherein the retention feature engages the wall of the artery to retain the sheath within the artery after the sheath has been introduced into the artery. | 08-06-2009 |
20100280431 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 11-04-2010 |
20110166496 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 07-07-2011 |
20110166497 | METHODS AND SYSTEMS FOR ESTABLISHING RETROGRADE CAROTID ARTERIAL BLOOD FLOW - Interventional procedures on the carotid arteries are performed through a transcervical access while retrograde blood flow is established from the internal carotid artery to a venous or external location. A system for use in accessing and treating a carotid artery includes an arterial access device, a shunt fluidly connected to the arterial access device, and a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state. The flow control assembly includes one or more components that interact with the blood flow through the shunt. | 07-07-2011 |
Patent application number | Description | Published |
20110098354 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and, a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 04-28-2011 |
20110098355 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 04-28-2011 |
20110105605 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 05-05-2011 |
Patent application number | Description | Published |
20100272831 | PROCESS FOR MANUFACTURING NANOCOMPOSITE MATERIALS FOR MULTISECTORAL APPLICATIONS - The present invention relates to a process for manufacturing intercalated nanocomposites with a layered structures, characterized in that they contain intercalated food, pharmaceutical or medical contact compliant organic materials and comprises the following steps:
| 10-28-2010 |
20110008440 | NOVEL NANOCOMPOUND MATERIALS WITH INFRARED, ULTRAVIOLET AND VISIBLE ELECTROMAGNETIC RADIATION BLOCKING PROPERTIES AND METHOD FOR OBTAINING THEM - The present invention refers to novel nanocomposite materials with protection properties against infrared and ultraviolet-visible radiation, to the method for obtaining them, which comprises the stages of reducing the size of the laminar particles by mechanical action, filtering, removing organic matter, removing crystalline oxides and hard particles that are not subject to modification, obtaining laminar fines or laminar structure, pre-treating laminar structures by means of precursors, and adding the product resulting from the previous stages in liquid or dry state to a plastic matrix. The invention also refers to the use of said materials for different industry fields. | 01-13-2011 |
20110288224 | Polymeric Matrix Nanocomposite Materials Having Improved Mechanical and Barrier Properties and Procedure For Preparing Same - The present invention relates to nanocomposite materials based on a polymeric or plastic matrix and a laminar silicate (clay) having improved mechanical, thermal and gas-barrier properties, among others, and not requiring clay-matrix compatibilising agents. Furthermore the present invention relates to three procedures for the obtainment of these materials and use thereof for applications such as in packaging products of interest to the food sector, among others, and for applications in other sectors. | 11-24-2011 |
Patent application number | Description | Published |
20090018194 | Use of antimicrobial agents derived from alliaceous plants for the prevention and control of crop diseases, post-harvest rot and as environmental disinifectant products - The present invention is directed to utilization of antimicrobial agents derived from plants of the alliaceae family for the prevention and control of crop diseases, post-harvest rotting and as environmental disinfection products. The agents include propyl propylthiosulfinate and propyl propylthiosulfonate compounds for pre- and post-harvest treatments, control of rotting in fruits and vegetables; disinfection of agricultural soils, control of microorganisms, environmental disinfection in agricultural processing industries, facilities and equipment, disinfection of food containers and boxes. The agents can be used as pure active principles or in mixtures, in aqueous solutions or in any formulation, either liquid or supported in a solid agent or formulation; as single active principles or in formulation, together with other synthetic or natural antifungal agents, biocontrol agents, fertilizers, antioxidants, growth regulators or regulators of any other type; by means of immersion, fogging, wetting, spraying, atomization, injection in the soil, in irrigation systems, by means of drenchers or in general any other treatment or application system. | 01-15-2009 |
Patent application number | Description | Published |
20100275285 | Method for obtaining a wheat plant with improve yield properties and a new type of wheat obtained by said method - The description of a method to obtain a wheat plant with improve yield properties that consists in the generation of genetic variability by means of the following stages: a) the construction of a wheat plant F1 by means of the crossing of two genetically distant parents and of opposed industrial qualities; b) the permanent application through the whole development of the inflorescence of said plant of a high concentration of sunlight without spectrum filtration; and c) the germination of the resulting seeds and the analysis of the descendants for the search of stable variants having different chromosomal number. Also, the description of wheat plants obtained in this way that preferably have crown root, high production capacity of fertile shoots, shoot capacity, perennial habit, high level of grain productivity, high protein level and industrial qualities similar to the hard wheat of best quality, that qualify to be designated as a new type of wheat commonly called Megawheat. The productivity level of the wheat plants described exceeds a 60% the production of the conventional wheat and yield seeds with a weight over 55 g, preferably over 70 g. | 10-28-2010 |
20130198891 | METHOD FOR OBTAINING A WHEAT PLANT WITH IMPROVED YIELD PROPERTIES AND A NEW TYPE OF WHEAT OBTAINED BY SAID METHOD - The description of a method to obtain a wheat plant with improve yield properties that consists in the generation of genetic variability by means of the following stages: a) the construction of a wheat plant FI by means of the crossing of two genetically distant parents and of opposed industrial qualities; b) the permanent application through the whole development of the inflorescence of said plant of a high concentration of sunlight without spectrum filtration; and c) the germination of the resulting seeds and the analysis of the descendants for the search of stable variants having different chromosomal number. Also, the description of wheat plants obtained in this way that preferably have crown root, high production capacity of fertile shoots, shoot capacity, perennial habit, high level of grain productivity, high protein level and industrial qualities similar to the hard wheat of best quality, that qualify to be designated as a new type of wheat commonly called Megawheat. The productivity level of the wheat plants described exceeds a 60% the production of the conventional wheat and yield seeds with a weight over 55 g, preferably over 70 g. | 08-01-2013 |
Patent application number | Description | Published |
20090237313 | MINIATURE ANTENNA FOR A MOTOR VEHICLE - The present invention relates to a miniature antenna for a motor vehicle. The antenna may, for example, be a printed board miniature radio antenna for AM/FM signal reception. The antenna may, for example, be placed in an internal mirror of a motor vehicle or on an exterior surface of the motor vehicle, such as the vehicle's roof. The antenna is shaped as a curve of conductive material in which the geometry of at least a part of said curve comprises a space-filling curve or a grid dimension curve. | 09-24-2009 |
20120038525 | FLUSH-MOUNTED LOW-PROFILE RESONANT HOLE ANTENNA - The invention relates to a flush-mounted aircraft, UAV or missile antenna system, which is an integral part of the fuselage ( | 02-16-2012 |
20150061946 | ANTENNA SYSTEM FOR A VEHICLE - Antenna system for a vehicle including a first directive antenna device and a second antenna device for a frequency band of operation, and a reflector plane, where the first directive antenna device includes a first ground plane, a first dielectric substrate, a first antenna group shorted to the first ground plane and having a first radiating conductor and a second radiating conductor, forming a first configuration and connected to the reflector plane by transmission lines electromagnetically coupled to the frequency band of operation, the reflector plane, disposed forming an angle with respect to the first dielectric substrate, the first directive antenna device radiating in a direction of radiation, and the second antenna device, connected to the first directive antenna device, radiating in an opposing direction to the first directive antenna device. | 03-05-2015 |
Patent application number | Description | Published |
20100093681 | NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR - The present disclosure relates to crystalline monoapadisylate and/or heminapadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, and pharmaceutically acceptable solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the crystalline monoapadisylate and/or heminapadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, and to methods of treatment comprising these pharmaceutical compositions. | 04-15-2010 |
20110195943 | NAPADISYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA 2 ADRENERGIC RECEPTOR - The present disclosure relates to crystalline monoapadisylate and/or heminapadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, and pharmaceutically acceptable solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the crystalline monoapadisylate and/or heminapadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, and to methods of treatment comprising these pharmaceutical compositions. | 08-11-2011 |
20110251234 | MESYLATE SALT OF 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE BETA2 ADRENERGIC RECEPTOR - The present disclosure relates to a mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the β2 receptor. | 10-13-2011 |
20120004414 | PROCESS FOR MANUFACTURING 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE - A process for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof, | 01-05-2012 |
Patent application number | Description | Published |
20080270757 | Fetch and Dispatch Disassociation Apparatus for Multistreaming Processors - A dynamic multistreaming processor has instruction queues, each instruction queue corresponding to an instruction stream, and execution units. The dynamic multistreaming processor also has a dispatch stage to select at least one instruction from one of the instruction queues and to dispatch the selected at least one instruction to one of the execution units. Lastly the dynamic multistreaming processor has a queue counter, associated with each instruction queue, for indicating the number of instructions in each queue, and a fetch counter, associated with each instruction queue, for indicating an address from which to obtain instructions when the associated instruction queue is not full. The dynamic multistreaming processor might also have fetch counters for indicating a next instruction address from which to obtain at least one instruction when the associated instruction queue is not full. The dynamic multistreaming processor could also have a second counter for indicating a next instruction address. | 10-30-2008 |
20090073974 | Method and Apparatus for Predicting Characteristics of Incoming Data Packets to Enable Speculative Processing To Reduce Processor Latency - A system for processing data packets in a data packet network has at least one input port for receiving data packets, at least one output port for sending out data packets, a processor for processing packet data, and a packet predictor for predicting a future packet based on a received packet, such that at least some processing for the predicted packet may be accomplished before the predicted packet actually arrives at the system. The system is used in preferred embodiments in Internet routers. | 03-19-2009 |
20090187739 | Method and Apparatus for Improved Computer Load and Store Operations - Load and store operations in computer systems are extended to provide for Stream Load and Store and Masked Load and Store. In Stream operations, a CPU executes a Stream instruction that indicates, by appropriate arguments, a first address in memory or a first register in a register file from whence to begin reading data entities, and a first address or register from whence to begin storing the entities, and a number of entities to be read and written. In Masked Load and Masked Store operations stored masks are used to indicate patterns relative to first addresses and registers for loading and storing. Bit-string vector methods are taught for masks. | 07-23-2009 |
20100103938 | Context Sharing Between A Streaming Processing Unit (SPU) and A Packet Management Unit (PMU) In A Packet Processing Environment - A context-selection mechanism is provided for selecting a best context from a pool of contexts for processing a data packet. The context selection mechanism comprises, an interface for communicating with a multi-streaming processor; circuitry for computing input data into a result value according to logic rule and for selecting a context based on the computed value and a loading mechanism for preloading the packet information into the selected context for subsequent processing. The computation of the input data functions to enable identification and selection of a best context for processing a data packet according to the logic rule at the instant time such that a multitude of subsequent context selections over a period of time acts to balance load pressure on functional units housed within the multi-streaming processor and required for packet processing. In preferred aspects, programmable singular or multiple predictive rules of logic are utilized in the selection process. | 04-29-2010 |
20100202292 | Mechanism for Achieving Packet Flow Control In a Multi-Threaded, Multi-Packet Environment - A processing engine to accomplish a multiplicity of tasks has a multiplicity of processing tribes, each tribe comprising a multiplicity of context register sets and a multiplicity of processing resources for concurrent processing of a multiplicity of threads to accomplish the tasks, a memory structure having a multiplicity of memory blocks, each block storing data for processing threads, and an interconnect structure and control system enabling tribe-to-tribe migration of contexts to move threads from tribe-to-tribe. The processing engine is characterized in that individual ones of the tribes have preferential access to individual ones of the multiplicity of memory blocks. | 08-12-2010 |
20120082167 | Method and Apparatus for Predicting Characteristics of Incoming Data Packets to Enable Speculative Processing to Reduce Processor Latency - A system for processing data packets in a data packet network has at least one input port for receiving data packets, at least one output port for sending out data packets, a processor for processing packet data, and a packet predictor for predicting a future packet based on a received packet, such that at least some processing for the predicted packet may be accomplished before the predicted packet actually arrives at the system. The system is used in preferred embodiments in Internet routers. | 04-05-2012 |
Patent application number | Description | Published |
20090220638 | Method for Producing Calcium Soaps for Animal Feed - The invention relates to a method for producing calcium soaps for animal feed. The invention consists of a novel process for producing calcium soaps, comprising the saponification of fats and natural oils with CaO, in which the reaction mass is heated and subjected to reduced pressure. In this way, calcium soaps with a fatty acid content of more than 80% can be obtained without requiring any subsequent washing or concentration process. Said high fatty acid content renders the soaps particularly suitable for use as a component of animal feed. The applicability of said soaps for feed for monogastric animals is improved by adding glycerol and/or another emulsifying agent during the soap production process. | 09-03-2009 |
20090297686 | Method of producing calcium, sodium or magnesium soaps from fatty acids or oleins from animal or vegetable fats and use thereof as nutrients in monogastric animal feed - Procedure for producing calcium, sodium or magnesium fatty acid soaps or vegetable or animal soapstocks and their use as nutrients in monogastric animal feeds. This procedure makes it possible to add glycerol, glycerol plus emulsifier or emulsifier to soaps, and simplifying the process by making the addition in the same production process. The use of these soaps in monogastric animals, such as pigs and fowl, decreases feeding costs compared to the use of whole fats (triglycerides) commonly used in the nutrition of monogastrics. The soaps are obtained in powder or granular form which is an advantage as regards currently giving it in liquid form. | 12-03-2009 |
20140037698 | ADDITIVES FOR ANIMAL FOOD - The present invention relates to the combination of organic acid salts with at least one active ingredient of plant origin, preferably essential oils, partially protected with vegetable fats and/or oils, which prevent these active ingredients from being digested by stomach enzymes during the digestive process. The sodium salts of short-chain acids, preferably salts of butyric, acid are preferred. The preferred essential oils are ginger, piperine, oregano, garlic, thymol, carvacrol, cinnamaldehyde and/or any combinations thereof. The combination of organic acid salts and the essential oils protected with vegetable fats and/or oils, are used as powerful promoters or stimulants for animal growth, as organic bactericides against pathogenic bacteria present in said animals and as modulators of immune response thereof. | 02-06-2014 |
Patent application number | Description | Published |
20090298781 | COMPOUNDS FOR THE INHIBITION OF APOPTOSIS - The present invention relates to compounds of formula (I) as well as to drug conjugates based on compounds of formula (I) acting as apoptosis inhibitors, as well as to processes for their preparation, to pharmaceutical compositions containing them and their use in medicine. | 12-03-2009 |
20100197606 | NON-PROTEOLYSABLE OLIGOPEPTIDES THAT INHIBIT GLYCOPROTEIN GP41 OF THE AIDS VIRUS - The invention relates to non-proteolysable oligopeptides that inhibit glycoprotein 41 of the AIDS virus. More specifically, the invention relates to the identification of oligopeptides, particularly hexapeptides, (D), (L) or mixed, preferably D-hexapeptides, which inhibit the binding of a retrovirus to a target cell, thereby providing novel therapies against infection from the human immunodeficiency virus (HIV). The invention also relates to the use of said D-hexapeptides in the form of single components or complex mixtures as prophylactic or therapeutic agents for retroviral infections, especially human immunodeficiency virus type 1 (HIV-1). | 08-05-2010 |
20110105545 | GPBP inhibition using Q2 peptidomimetics - Disclosed are compounds of formula: | 05-05-2011 |
20130143825 | COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF TOXIC TRANSCRIPTS - Compounds to be used in the treatment of diseases based on the expression of toxic transcripts. The present invention relates to peptide molecules, specifically hexapeptides, designed for the prevention and/or treatment of diseases the etiology whereof is based on the presence of toxic transcripts that comprise CUG, CCUG, CGG, CAG and AAG repeats, preferably: DM1 SCA8, DM2, FXTAS, HD and FA. | 06-06-2013 |
20140080852 | GPBP inhibition using Q2 peptidomimetics - Disclosed are compounds of formula: | 03-20-2014 |
Patent application number | Description | Published |
20090281790 | DYNAMIC LANGUAGE TRANSLATION OF WEB SITE CONTENT - A method, system and computer program product for providing translated web content is disclosed. The method includes receiving a request from a user on a web site, the web site having a first web content in a first language, wherein the request calls for a second web content in a second language. The method further includes dividing the first web content into a plurality of translatable components and generating a unique identifier for each translatable component. The method further includes identifying a plurality of translated components of the second web content using the unique identifier of each of the plurality of translatable components of the first web content and putting the plurality of translated components of the second web content to preserve a format that corresponds to the first web content. The method further includes providing the second web content in response to the request that was received. | 11-12-2009 |
20100030550 | SYNCHRONIZATION OF WEB SITE CONTENT BETWEEN LANGUAGES - A system, method and computer readable medium for synchronizing web content is disclosed. The method includes retrieving a first web content in a first language from a web site, the first web content corresponding to a second web content wherein the second web content is a translation in a second language of the first web content. The method further includes dividing the first web content into a plurality of translatable components and generating a unique identifier for each of the plurality of translatable components. The method further includes matching each of the plurality of translatable components to a plurality of translated components of the second web content using the unique identifier of each of the plurality of translatable components. If a translatable component is not matched to a translated component, the method further includes designating the translatable component for translation into the second language. | 02-04-2010 |
20100169764 | AUTOMATION TOOL FOR WEB SITE CONTENT LANGUAGE TRANSLATION - A system, method and computer readable medium for providing translated web content is disclosed. The method on an information processing system includes retrieving a first content in a first language and parsing the first content into a plurality of translatable components. The method further includes generating a unique identifier for each of the plurality of translatable components of the first content and queuing the plurality of translatable components and corresponding unique identifiers for translation into a second language. The method further includes, for each of the plurality of translatable components, storing a translated component and an associated unique identifier corresponding to the translatable component, thereby storing a plurality of translated components and corresponding unique identifiers. | 07-01-2010 |
20100174525 | ANALYZING WEB SITE FOR TRANSLATION - A system, method and computer readable medium for synchronizing web content is disclosed. The method includes retrieving a first web content in a first language from a web site, the first web content corresponding to a second web content wherein the second web content is a translation in a second language of the first web content. The method further includes dividing the first web content into a plurality of translatable components and generating a unique identifier for each of the plurality of translatable components. The method further includes matching each of the plurality of translatable components to a plurality of translated components of the second web content using the unique identifier of each of the plurality of translatable components. If a translatable component is not matched to a translated component, the method further includes designating the translatable component for translation into the second language. | 07-08-2010 |
20110209038 | DYNAMIC LANGUAGE TRANSLATION OF WEB SITE CONTENT - A method, system and computer program product for providing translated web content is disclosed. The method includes receiving a request from a user on a web site, the web site having a first web content in a first language, wherein the request calls for a second web content in a second language. The method further includes dividing the first web content into a plurality of translatable components and generating a unique identifier for each translatable component. The method further includes identifying a plurality of translated components of the second web content using the unique identifier of each of the plurality of translatable components of the first web content and putting the plurality of translated components of the second web content to preserve a format that corresponds to the first web content. The method further includes providing the second web content in response to the request that was received. | 08-25-2011 |
Patent application number | Description | Published |
20090088341 | MULTIPLEX ASSAY METHOD FOR MIXED CELL POPULATIONS - Disclosed is an in vitro assay for evaluating cellular activity, in which a culture is provided that contains one or more histologically different isolated mammalian cell-line that stably and constitutively express fluorescent proteins having a different emission spectra. The culture is assessed for cellular activity by quantifying fluorescence or detecting a pattern of fluorescence from fluorescent proteins present in the culture. In some embodiments, the cellular activity of the cell-lines is assessed by determining one or more of the growth rate, migration potential, or tubule formation potential of the cell-lines using the quantified fluorescence or pattern of fluorescence. Also disclosed are cell-lines have been stably transfected with mammalian expression plasmids that constitutively express different fluorescent proteins. Kits for performing the disclosed assays, which include the disclosed fluorescent cell-lines, are also disclosed. | 04-02-2009 |
20100255528 | Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures - This disclosure relates to fluorescent cell lines and to the use of such cell lines in monitoring cellular activity, such as angiogenesis. This disclosure further relates to the use of such cell lines in a three-dimensional cell culture to monitor angiogenic and metastatic potential of tumor cells and selecting personalized therapeutics for treatment of cancer. | 10-07-2010 |
20120129775 | ANTIANGIOGENIC SMALL MOLECULES AND METHODS OF USE - Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof. | 05-24-2012 |
20140155292 | METHODS OF MONITORING ANGIOGENESIS AND METASTASIS IN THREE DIMENSIONAL CO-CULTURES - This disclosure relates to fluorescent cell lines and to the use of such cell lines in monitoring cellular activity, such as angiogenesis. This disclosure further relates to the use of such cell lines in a three-dimensional cell culture to monitor angiogenic and metastatic potential of tumor cells and selecting personalized therapeutics for treatment of cancer. | 06-05-2014 |